- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
心力衰竭BNP-Hardy.Alere
BNP的临床意义:脑钠肽的分泌 心肌细胞 preproBNP (134 aa) 信号肽 (26 aa) proBNP (108 aa) 血液 BNP 77- 108 (1-32) NT-proBNP 1-76 分泌 摘自: J. Mair et al. Scand J Clin Lab Invest 1999; 59 (suppl 230) : 132-142 (生理活性部分) (无活性) BNP vs. NT-proBNP BNP NT-proBNP 分子结构 BNP77-108 NT-proBNP1-76 生物活性 有 无 半衰期 20min 60-120min 清除 主动清除和被动清除 被动清除 标本要求 EDTA抗凝血浆 血清、血浆、全血 试管 塑料管 玻璃管或塑料管 临床参考值 不受年龄限制、便于解读 与年龄相关,需结合患者年龄进行解读 不同温度保存不同时间对BNP与NT-proBNP在样本中的稳定性影响 摘自:王伟佳,张秀明,温冬梅,欧阳能良。不同抗凝剂、样本放置时问及保存温度对B型利钠肽和氨基末端B型利钠肽原检测的影响[J],现代检验医学杂志2012,27(2):83-87. * * 临床参考值 BNP Januzzi et al. Eur Heart J 2006; 27:330-7 (Roche method) PPV 95% NPV = 98% 500 Mehra et al. Crit Pathways in Cardiol 2005;4:10-20 (Alere method) 50 yrs 50-75 yrs 75 yrs HF Rule-in HF Rule-out HF Possible 100 No age distinction PPV = 88% NPV = 98% 450 300 900 1800 NT-proBNP 谢谢! * * * * * The Triage? BNP Test is indicated for use as an aid in the diagnosis of congestive heart failure. * In 325 patients presenting to the ED with dyspnea, BNP levels were determined. Patients were then followed for 6 months looking for the following endpoints: death (cardiac and non-cardiac), hospital admissions (cardiac), and repeat ED visits for CHF. Using Kaplan-Meyer plots for all CHF events, patients who left the emergency department with BNP levels 480 pg/ml had a 6-month cumulative probability of a CHF event of (43%). On the other hand, patients who left the emergency department with BNP levels 230 pg/ml had an excellent prognosis with only 2.5% incidence of CHF end-points. The odds ratio for 6-month CHF death in patients with BNP levels 230 was 46. BNP levels measured in patients presenting with dyspnea to the ED are highly predictive of future cardiac events. Utilization of BNP levels in patients presenting with symptoms of CHF should prove to be a cost-effective way to risk-stratify patients with HF. Study Objective: B-Type natriuretic peptide (BNP) is a neurohormone secreted from the cardiac ventricles in response to volume expansion and pressure
文档评论(0)